Received via their PR let’s say that as I’ve seen elsewhere caution is the name of the game…
I, on the other hand don’t have to be cautious and looking through the prism of the last few weeks as an outsider I’d suggest that positive changes on the federal front are shall we say negligible and it’s probably just best to keep one’s head down, get on with the work and engage on a state level where admisnistrations have already become addicted to the tax revenue , something they’ll need more of as the tariff stupidity plays through the economy.
Pam Bondi and Doug Collins Confirmations
Collins
NewLake Capital Partners, Inc. (OCTQX: NLCP)
CEO Anthony Coniglio
Doug Collins’ potential appointment as Secretary of Veterans Affairs brings optimism for the cannabis industry, particularly regarding its intersection with veteran healthcare. As a former congressman and sponsor of the STATES Act, Collins has demonstrated a willingness to support legislation that empowers states to shape cannabis policy, reflecting a pragmatic approach to this evolving sector.
Collins’ background as a strong advocate for veterans’ healthcare and his legislative experience could pave the way for expanded access to medical cannabis for veterans, particularly for conditions such as PTSD and chronic pain. His leadership at the VA could help address long-standing barriers, such as the inability of VA physicians to discuss or prescribe cannabis due to federal restrictions. Legislative action to permit such discussions would not only validate the medical efficacy of cannabis but also create momentum for broader federal reform, including rescheduling.
We see potential federal support from leaders like Collins as a key opportunity to expand patient access and drive industry growth. Any progress at the federal level would validate the efforts already undertaken at the state level and further solidify cannabis as an essential component of modern healthcare.
While we recognize that federal reform requires time and effort, Collins’ leadership at the VA could act as a catalyst for change, encouraging policymakers to advance reforms that benefit veterans and create a ripple effect across the broader cannabis industry. We remain committed to supporting operators who are delivering solutions in limited-license states and stand ready to engage with policymakers like Collins to highlight the importance of cannabis in improving healthcare outcomes and fostering economic growth.
Pam Bondi – NewLake Capital Partners, Inc. (OCTQX: NLCP) CEO Anthony Coniglio
Pam Bondi’s confirmation as Attorney General brings both anticipation and uncertainty to the cannabis industry. Her historically conservative stance on cannabis, shaped by her tenure as Florida’s Attorney General, highlights her cautious approach to cannabis reform. However, her alignment with the Trump Administration’s recent signals toward common-sense cannabis policies may indicate a shift toward a more pragmatic perspective.
As Attorney General, Bondi will wield significant influence over regulatory decisions, as evidenced by the current rescheduling process. Having previously served as Florida’s Attorney General, she is well-acquainted with cannabis policy and its broader impacts. While her specific position on cannabis reform remains unclear, we expect to have more light shed on her stance in the coming weeks and months.
Federal attitudes are gradually evolving in favor of cannabis reform, supported by an administration increasingly inclined to allow states to lead on policy and regulation. This approach aligns with the industry’s needs and would create a supportive environment for state-level initiatives to continue driving growth. However, federal reform will take time, as cannabis is likely to remain a lower priority compared to other pressing issues, such as deregulation and international trade.
We remain focused on supporting cannabis operators in limited-license states, where state-led efforts continue to drive meaningful progress. While the path to federal reform is gradual, any steps that improve access to capital or provide regulatory clarity will present transformative opportunities for businesses and investors alike.
We look forward to engaging with policymakers, including Attorney General Bondi, to highlight the economic, social, and medical benefits of a thriving cannabis industry. By fostering constructive dialogue, we can work toward a federal framework that supports innovation, public health, and economic growth for communities across the nation.
Statement on Derek S. Maltz’s Appointment as Acting Administrator of the DEA
The appointment of Derek S. Maltz as Acting Administrator of the DEA comes at a critical time for the cannabis industry, as the agency holds the final decision on rescheduling. While Acting Administrator Maltz has previously voiced skepticism toward cannabis policy reform, he has also stated that he will defer to the science. If that commitment holds, the comprehensive 252-page HHS analysis, combined with the fact that over 40 states have legalized medical cannabis with the backing of their medical advisory boards, should provide a clear foundation for rescheduling. However, concerns remain regarding his past statements linking cannabis use to public safety issues, which contradict the growing body of research supporting cannabis’ medicinal benefits. Ultimately, we hope that Acting Administrator Maltz follows the scientific consensus and ensures that DEA policy aligns with both public health data and the realities of a regulated cannabis market.
Pam Bondi
CEO Adam Wilks
As we continue to see cannabis policy evolve at the federal level, it’s important to recognize that leadership plays a pivotal role in shaping the future of this industry. While Pam Bondi’s record as Florida Attorney General reflected a cautious approach toward cannabis, we remain optimistic that any future policymaking under her leadership as Attorney General will reflect the broader shifts we are seeing across the nation. More Americans than ever support sensible cannabis reform, and we hope that any incoming administration will prioritize the economic opportunities, medical potential, and public safety benefits of a modernized approach to cannabis policy.
Carma HoldCo is committed to driving growth and innovation in the evolving cannabis industry, leveraging opportunities created by progressive state and federal reforms. We believe in forward-thinking leadership that respects states’ rights, supports cannabis businesses, and listens to the millions of patients and consumers who benefit from this industry. We look forward to seeing policies that ensure growth, innovation, and safe access for all.
Collins
Veterans Exploring Treatment Solutions (VETS)
Amber Capone, Co-Founder and CEO
In the first 100 days of this administration, an estimated 2,000 veterans will lose their lives to suicide. Too many continue to struggle, and we believe that by working together, we can create meaningful change that saves lives and strengthens families.
Doug Collins’ long-standing commitment to veterans’ healthcare, coupled with his legislative experience, positions him to champion innovative solutions that support the well-being of those who have served. As Secretary of Veterans Affairs, he has the opportunity to help expand access to a full range of treatment options, ensuring that veterans and their families receive the care they deserve.
This is a moment to bring people together around a shared mission: helping veterans not just survive, but truly thrive. Veterans Exploring Treatment Solutions (VETS) stands ready to collaborate with Secretary Collins and this administration to explore bold, effective solutions that honor our commitment to those who have sacrificed for our country.